Take Charge of Your Diabetes
- Conditions
- DiabetesHypertension
- Registration Number
- NCT01977495
- Lead Sponsor
- University of Pennsylvania
- Brief Summary
The investigator plans to assess enrollment rates among two different enrollment methods, while providing a behavioral economic intervention to enhance the uptake of home-health monitoring devices to lower hemoglobin A1C among patients with uncontrolled diabetes. The study is focusing on enrollment methods since the standard randomized control trial only reaches 15% of the population. The study is seeking to understand the effectiveness of a behavioral intervention, when rolled out in a larger population.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 136
- Adults between 18 and 80 years of age
- Primary care patients at the Division of General Internal Medicine clinics at the University of Pennsylvania
- Hemoglobin A1c measured within the last 8 weeks greater than 8.0% OR no measured Hemoglobin A1C measured in the last two years
- A confirmed diabetes diagnosis
- Planning to stay in area for study duration (6 months)
- Can understand and communicate fluently in English
- Unable to read and give consent
- Suffer from an uncontrolled psychiatric disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Enrollment and participation rates End of study- 6 months after enrollment The primary objective is to obtain preliminary evidence regarding whether or not patients opt-into a research study, as opposed to enrolling by default, will affect participation in the program and the effectiveness of the intervention, among high-risk patients. The primary outcome is to measure enrollment rates. The investigators will also measure participation in the program through device usage.
- Secondary Outcome Measures
Name Time Method Uptake of Device Usage End of study- 6 months after enrollment Assess the effect of financial incentives on the use of home health monitoring devices among high-risk patients
Trial Locations
- Locations (1)
University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States